From: Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC)
Clinical characteristics | univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Age | 1.033 (1.020–1.047) | 0.000 | 1.039 (1.023–1.054) | 0.000 |
Gender | 0.933 (0.680–1.282) | 0.670 | 0.938 (0.678–1.298) | 0.700 |
Race | 1.193 (0.716–1.988) | 0.498 | 1.043 (0.611–1.779) | 0.877 |
Grade | 1.967 (1.639–2.361) | 0.000 | 1.460 (1.162–1.834) | 0.001 |
Stage | 1.856 (1.644–2.095) | 0.000 | 1.778 (1.245–2.538) | 0.002 |
T | 1.998 (1.689–2.362) | 0.000 | 1.039 (0.785–1.375) | 0.790 |
M | 2.100 (1.661–2.655) | 0.000 | 0.797 (0.417–1.525) | 0.494 |
N | 0.862 (0.739–1.008) | 0.063 | 0.848 (0.722–0.995) | 0.043 |
PHYH | 0.963 (0.941–0.986) | 0.002 | 0.975 (0.954–0.996) | 0.021 |